Ensitrelvir (S-217622) Yepakati CAS 1360105-53-8 Kuchena >98.0% COVID-19

Tsanangudzo Pfupi

Kemikari Zita: 1,3,5-Triazine-2,4(1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)-

CAS: 1360105-53-8

Kuchena:> 98.0% (HPLC)

Pakati peEnsitrelvir (S-217622), COVID-19

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Tumira email kwatiri

Product Detail

Product Tags

Tsanangudzo:

Commercial Supply Ensitrelvir (S-217622) Pakati:
S-Ethylisothiourea Hydrobromide CAS 1071-37-0
2,4,5-Trifluorobenzyl Bromide CAS 157911-56-3
Trimethyloxonium Tetrafluoroborate CAS 420-37-1
6-Chloro-2-methyl-2H-indazol-5-amine CAS 1893125-36-4
3-(Chloromethyl) -1-methyl-1H-1,2,4-triazole hydrochloride CAS 135206-76-7
1,3,5-Triazine-2,4(1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)- CAS 1360105-53-8

Chemical Properties:

Chemical Name	1,3,5-Triazine-2,4(1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)-
Mashoko anoreva zvakafanana	3-tert-butyl-6-(ethylthio)-1,3,5-triazine-2,4(1H,3H)-dione
Nhamba yeCAS	1360105-53-8
Nhamba yeCAT	RF-PI1504
Stock Status	Mudura
Molecular Formula	C9H15N3O2S
Molecular Weight	229.3
Brand	Ruifu Chemical

Zvinotsanangurwa:

Item	Zvinotsanangurwa
Kuchena	>98.0%
Kurasika paKuomesa	<1.00%
Zvose Zvisina Kuchena	<2.00%
Test Standard	Enterprise Standard
Usage	Pakati peEnsitrelvir (S-217622), COVID-19

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro.

Zvakanakira:

FAQ:

Application:

3-(Chloromethyl) -1-methyl-1H-1,2,4-triazole hydrochloride (CAS: 135206-76-7) iri pakati peEnsitrelvir (S-217622).Ensitrelvir mushonga unorwisa hutachiona wakagadzirwa neShionogi mukubatana neHokkaido University, unoshanda semumuromo unoshanda 3C-senge protease inhibitor pakurapa hutachiona hweCOVID-19.Inotorwa nemuromo, uye yakayedzwa zvakabudirira inopesana neachangobva kubuda Omicron musiyano.Yakave piritsi rekutanga remumba rekuJapan kurapa COVID-19, yechitatu kubvumidzwa zviri pamutemo muJapan;muna Kukadzi 2022.